Anti cancer drug discovery

Anti-cancer drug discovery is the process of identifying and developing drugs that can effectively treat cancer. This process typically involves several stages, including target identification, lead discovery, lead optimization, preclinical testing, and clinical trials.

Target identification involves identifying specific molecules or pathways that play a critical role in the development or progression of cancer. Once a target has been identified, researchers can screen large libraries of compounds to identify potential leads, or drug candidates, that can interact with the target and inhibit its activity.

Lead optimization involves optimizing the properties of a lead compound to improve its potency, selectivity, and pharmacokinetics, or the way the drug is absorbed, distributed, metabolized, and eliminated by the body. Preclinical testing involves testing the drug candidate in laboratory and animal models to evaluate its safety and efficacy before it can be tested in humans.

If the drug candidate shows promising results in preclinical testing, it can then proceed to clinical trials, which involve testing the drug in human volunteers or patients. Clinical trials typically involve three phases, each with increasing numbers of participants, to evaluate the safety, efficacy, and optimal dose of the drug.

Anti-cancer drug discovery is a complex and time-consuming process that can take several years or even decades to complete. However, the development of new cancer drugs has led to significant improvements in the treatment and survival of cancer patients. Advancements in technology, such as high-throughput screening and computational modeling, have helped to accelerate the drug discovery process and improve the success rate of drug development.

 

    Related Conference of Anti cancer drug discovery

    June 21-22, 2023

    11th International Heart Conference

    Rome, Italy
    July 03-04, 2023

    12th World Heart Congress

    Paris, France
    July 17-18, 2023

    4th Global Conference on Cardiology & Heart Diseases

    Vienna, Austria
    July 21-22, 2023

    3rd World Congress on Congestive Heart Failure & Angina

    Amsterdam, Netherlands
    August 14-15, 2023

    6th World Heart and Brain Conference

    Dublin, Ireland
    August 14-15, 2023

    5th Annual Conference on Vascular Medicine

    Dublin, Ireland
    August 23-24, 2023

    23rd World Congress on Cancer and Diagnostics

    Toronto, Canada
    August 24-25, 2023

    4th Annual Summit on Cardiology and Heart Diseases

    Toronto, Canada
    September 14-15, 2023

    2nd International Congress on Heart

    Singapore City, Singapore
    September 18-19, 2023

    27th International Conference on Cardiology and Vascular Imaging

    Amsterdam, Netherlands
    September 25-26, 2023

    17th International Congress on Autoimmunity

    Prague, Czech Republic
    September 25-26, 2023

    2nd International Conference on World Heart Care

    Zurich, Switzerland
    October 26-27, 2023

    27th World Cardiology Conference

    Toronto, Canada
    October 30-31, 2023

    6th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    November 13-14, 2023

    38thEuropean Cardiology Conference

    London, UK
    November 13-14, 2023

    35th Annual Cardiologists Conference

    Barcelona, Spain
    November 20-21, 2023

    4th Global Summit On Heart Congress

    Dubai, UAE
    November 23-24, 2023

    5th Euro Cardiology Congress

    Amsterdam, Netherlands
    November 27-28, 2023

    31st World Heartcare Summit

    Montreal, Canada
    February 19-20, 2024

    36th World Congress on Cardiology & Heart Diseases

    London, UK
    May 13-14, 2024

    38th World Congress on Heart Diseases

    Amsterdam, Netherlands

    Anti cancer drug discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in